Global Information
회사소개 | 문의

세계의 동물용 백신 시장 조사 및 예측

Global Animal Vaccine Market Research and Forecast, 2018-2023

리서치사 Orion Market Research Pvt Ltd
발행일 2018년 04월 상품 코드 637928
페이지 정보 영문
가격
US $ 3,600 ₩ 4,105,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 인쇄가 불가능합니다.
US $ 4,800 ₩ 5,473,000 PDF (Enterprise License) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. PDF 파일은 인쇄 가능하며 이용 인원수에 제한이 없습니다.

주의 : 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다.
자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 동물용 백신 시장 조사 및 예측 Global Animal Vaccine Market Research and Forecast, 2018-2023
발행일 : 2018년 04월 페이지 정보 : 영문

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

세계의 동물용 백신 시장에 대해 조사분석했으며, 시장 개요, 시장 동향, 경쟁 구도, 지역별 시장 분석, 기업 개요 등을 정리하여 전해드립니다.

제1장 리포트 요약

  • 조사 방법과 툴
  • 시장 개요

제2장 시장 개요와 인사이트

  • 정의
  • 애널리스트의 인사이트와 현재 시장 동향
  • 규제
  • 파이프라인 분석

제3장 시장 결정요인

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회

제4장 시장 세분화

  • 세계의 동물용 백신 시장 : 종류별
  • 세계의 동물용 백신 시장 : 기술별

제5장 경쟁 구도

  • 주요 전략
  • 주요 기업 분석

제6장 지역별 분석

  • 북미
  • 유럽
  • 아시아태평양
  • 세계 기타 국가

제7장 기업 개요

  • BAYER ANIMAL HEALTH
  • BIOGENESIS BAGO A.S
  • MERIAL(BOEHRINGER INGELHEIM)
  • CEVA ANIMAL HEALTH LLC
  • ELANCO(A DIVISION OF ELI-LILLY)
  • HESTER BIOSCIENCES LIMITED
  • HIPRA
  • HYGIEIA BIOLOGICAL LABORATORIES
  • INDOVAX PVT. LTD.
  • JINYU BIO-TECHNOLOGY CO. LTD.
  • MSD ANIMAL HEALTH
  • NEOGEN CORPORATION
  • NISSEIKEN CO. LTD.
  • TEXAS VET LAB, INC.
  • UNITED VACCINES, INC.
  • VIRBAC S.A
  • VENTOQUINOL S.A
  • ZOETIS INC.
KSA 18.05.30

List of Tables

  • TABLE # 1 GLOBAL ANIMAL VACCINE MARKET RESEARCH AND ANALYSIS, BY TYPE, 2017-2023 ($ MILLION)
  • TABLE # 2 GLOBAL PORCINE VACCINE MARKET RESEARCH AND ANALYSIS 2017-2023($ MILLION)
  • TABLE # 3 GLOBAL POULTRY VACCINES MARKET RESEARCH AND ANALYSIS, 2017-2023, ($MILLION)
  • TABLE # 4 GLOBAL LIVESTOCK VACCINE MARKET RESEARCH AND ANALYSIS, 2017-2023, ($ MILLION)
  • TABLE # 5 GLOBAL AQUACULTURE VACCINES MARKET RESEARCH AND ANALYSIS, 2017-2023, ($ MILLION)
  • TABLE # 6 GLOBAL COMPANION VACCINES MARKET RESEARCH AND ANALYSIS, 2017-2023, ($ MILLION)
  • TABLE # 7 GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS, 2017-2023, ($ MILLION)
  • TABLE # 8 GLOBAL ANIMAL VACCINE MARKET RESEARCH AND ANALYSIS, BY TECHNOLOGY, 2017-2023, ($ MILLION)
  • TABLE # 9 GLOBAL LIVE WHOLE VIRUS VACCINES MARKET RESEARCH AND ANALYSIS, 2017-2023, ($ MILLION)
  • TABLE # 10 GLOBAL KILLED WHOLE VIRUS VACCINES MARKET RESEARCH AND ANALYSIS, 2017-2023, ($ MILLION)
  • TABLE # 11 GLOBAL SUB-UNIT VACCINES MARKET RESEARCH AND ANALYSIS, 2017-2023, ($ MILLION)
  • TABLE # 12 GLOBAL RECOMBINANT VIRUS VACCINES MARKET RESEARCH AND ANALYSIS, 2017-2023, ($ MILLION)
  • TABLE # 13 GLOBAL ANTI-IDIOTYPE ANTIBODIES VACCINE MARKET RESEARCH AND ANALYSIS, 2017-2023, ($ MILLION)
  • TABLE # 14 GLOBAL DNA VACCINES MARKET RESEARCH AND ANALYSIS, 2017-2023, ($ MILLION)
  • TABLE # 15 GLOBAL GENE DELETED MARKER VACCINES MARKET RESEARCH AND ANALYSIS, 2017-2023, ($ MILLION)
  • TABLE # 16 GLOBAL CHIMERIC VACCINES MARKET RESEARCH AND ANALYSIS, 2017-2023, ($ MILLION)

List of Figures

  • FIGURE # 1 GLOBAL ANIMAL VACCINES MARKET RESEARCH AND ANALYSIS, BY TYPE 2017 VS 2023, (%)
  • FIGURE # 2 GLOBAL ANIMAL VACCINE MARKET RESEARCH AND ANALYSIS, BY TECHNOLOGY, 2017 VS 2023, (%)
  • FIGURE # 3 GLOBAL ANIMAL VACCINE MARKET RESEARCH AND ANALYSIS, BY REGION, 2017 VS 2023, (%)
  • FIGURE # 4 NORTH AMERICA MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • FIGURE # 5 US MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • FIGURE # 6 CANADA MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • FIGURE # 7 EUROPEAN MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • FIGURE # 8 UK MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • FIGURE # 9 FRANCE MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • FIGURE # 10 GERMANY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • FIGURE # 11 ITALY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • FIGURE # 12 SPAIN MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • FIGURE # 13 ROE MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • FIGURE # 14 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • FIGURE # 15 INDIA MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • FIGURE # 16 CHINA MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • FIGURE # 17 JAPAN MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • FIGURE # 18 ROAPAC MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • FIGURE # 19 REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)

The global animal vaccine market is anticipated to grow at the CAGR of 6.5% during the forecast period (2018-2023). Vaccination have a significant part in protecting animal and public health. Vaccination of animals ensures the prevention of possibly hazardous infectious diseases and sustain the productivity of animal protein production. The growing trend of adoption of pets is triggering the growth of the market by creating high demands for animal vaccines. Pets are vaccinated against infectious diseases such as rabies, distemper, and hepatitis. According to the European Pet Food Industry Federation, 80 million households owned pet animals in the European Union in 2016 of which 18% were pet dogs and 26% pet cats. France, Italy, the UK., Ukraine and Germany were in the list of top ten countries with the largest cat population, while France and Romania had the largest dog population in Europe. Leptospirosis is one of the key bacterial diseases which occur in 60% of UK dairy herds. The most common preventive measure for this disease is vaccination. In US, an estimated 78 million dogs and 85.8 million cats are owned accounting for 44% households owing dogs, and 35% owing cat, according to American Pet Products Association 2015-2016.

The factors contributing to the growth of the market include the increasing incidences of zoonotic diseases, factory farming method leading to many diseases among animals, and diseases due to climate change. The introduction of new animal vaccines by the major key companies such as Zoetis, and Boehringer Ingelheim for animal health is further augmenting the growth of the market. Initiatives taken by several governments such as the European government and animal wellness programs led by various animal welfare organisations is driving the market growth. Animal Association of Avian Pathologists, American Feed Industry Association, and National Turkey Federation are some of the animal welfare organizations actively working for animal health.

However, strict and complex regulatory policies delay the reach of vaccines in the market. The storage of vaccines adds to maintenance costs as proper temperature conditions are needed for its storage. These are hindering the growth of the market. Increasing awareness regarding animal welfare, government initiatives to support R&D will have positive growth outlook for the market in the future.

The animal vaccine market is segmented on the basis of type and technology. On the basis of type of vaccines, the market is bifurcated into porcine vaccines, poultry vaccines, livestock vaccines, aquaculture vaccines, companion animal vaccines and other animal vaccines. On the basis of technology, the market is segmented into live whole virus vaccines, killed whole virus vaccines, subunit vaccines, recombinant virus vaccines, anti-idiotype antibodies, DNA vaccines, gene deleted marker vaccines, chimeric vaccines. The live whole virus vaccines segment is expected to account for one of the largest share of the market in 2017 due to the ease of administration and long-term immunity offered by the live attenuated vaccine technologies.

The global animal vaccine market is analysed on the basis of the geographical regions that are contributing significantly towards the growth of the market. North America is expected to be the largest market for animal vaccines market, followed by Europe. High adoption rate of pets, high meat consumption and their mandatory vaccination are the major factors for the US market share. APAC region is estimated to be the fastest growing market during the forecast period - due to its increasing consumption and trade of meat. China's increasing demand for meat is making it one of the lucrative markets for animal healthcare products for food animals. China consumes around 28% of the world's meat according to the Organisation for Economic Co-operation and Development and The Food and Agriculture Organization of the United Nations FAO in 2014 accounting for 86,000 tonnes of meat. China consumed about 25% of the total meat produced globally in 2012 with the consumption of 71.2 million tons according to United States Department of Agriculture (USDA). Additionally, it is the largest swine meat consumer globally as well.

The companies contributing to the growth of global animal vaccine market are Zoetis, Elanco(Eli-Lilly), Merck & Co. Inc., Boehringer Ingelheim Bayer, Ceva Animal Health, Valneva Technologies, and Virbac S.A and so on. Majority of key players are acquiring or entering into strategic alliance with other key players from the market to gain a competitive edge over others and enhance their presence. Recently in January 2017, Valneva signed a research license agreement with Merck Animal Health which grants Merck the rights to research new vaccine candidates using Valneva's EB66 technology. In January 2017, Boehringer Ingelheim completed the acquisition of Merial, animal healthcare division of Sanofi, for the expansion of its business.

Market Segmentation

  • Global animal vaccine market by type
  • Global animal vaccine market by technology

Research Methodology

The market study of animal vaccines market is incorporated by extensive primary and secondary research conducted by research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings the authenticity in our reports.

Secondary sources include:

  • Financial reports of companies involved in the market
  • Authentic Public Databases
  • Whitepapers, research-papers and news blogs
  • Company websites and their product catalogue.
  • Supplier Websites such as Alibaba, amazon for pricing analysis.

The report provides in-depth analysis on pricing, market size, intended quality of the product preferred by consumers, initial norms and vehicle segment. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models such as PEST analysis, Porter five analysis delivering insights into the market for better business decisions.

THE REPORT COVERS:

  • Comprehensive research methodology of global animal vaccine market.
  • This report also includes detailed and extensive market overview with analyst insights & key market trends.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global animal vaccine market.
  • Insights about market determinants which are stimulating the global animal vaccine market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. REPORT SUMMARY

  • 1.1. RESEARCH METHODS AND TOOLS
  • 1.2. MARKET BREAKDOWN
    • 1.2.1. BY SEGMENTS
    • 1.2.2. BY GEOGRAPHY
    • 1.2.3. BY STAKEHOLDERS

2. MARKET OVERVIEW AND INSIGHTS

  • 2.1. DEFINITION
  • 2.2. ANALYST INSIGHTS & CURRENT MARKET TRENDS
    • 2.2.1. KEY FINDINGS
    • 2.2.2. RECOMMENDATION
    • 2.2.3. CONCLUSION
  • 2.3. REGULATIONS
    • 2.3.1. UNITED STATES
    • 2.3.2. EUROPEAN UNION
    • 2.3.3. CHINA
    • 2.3.4. INDIA
    • 2.3.5. REST OF THE WORLD
  • 2.4. PIPELINE ANALYSIS

3. MARKET DETERMINANT

  • 3.1. MOTIVATORS
    • 3.1.1. INCREASING ADOPTION OF PETS AS COMPANIONS
    • 3.1.2. RISING ZOONOTIC DISEASES
    • 3.1.3. INCREASING MEAT PRODUCTION
    • 3.1.4. FACTORY FARMING LEADING TO VARIOUS DISEASES IN ANIMALS
    • 3.1.5. ANIMAL DISEASES ON RISE DUE TO CLIMATE CHANGE
    • 3.1.6. INTRODUCTION OF NEW VETERINARY VACCINES BY ANIMAL HEALTH COMPANIES
    • 3.1.7. GLOBAL RISE IN WELLNESS AND VACCINATION PROGRAMMES BY ANIMAL WELFARE ORGANISATIONS
  • 3.2. RESTRAINTS
    • 3.2.1. HIGH MAINTAINENCE COSTS AS PROPER TEMPERATURE IS REQUIRED FOR STORAGE
    • 3.2.2. INCREASING COMPLEXITY IN REGULATORY REQUIREMENTS AND POLICIES
    • 3.2.3. CHALLENGES FACED IN R&D DUE TO SIDE-EFFECTS OR NEW TECHNOLOGIES
  • 3.3. OPPORTUNITIES
    • 3.3.1. INCREASING AWARENESS OF ANIMAL HEALTH TO TRIGGER MARKET GROWTH
    • 3.3.2. RISE IN VACCINATION CAMPAIGNS
    • 3.3.3. INITIATIVES TO SUPPORT VETERINARY R&D FOR ANIMAL VACCINE

4. MARKET SEGMENTATION

  • 4.1. GLOBAL ANIMAL VACCINE MARKET BY TYPE
    • 4.1.1. PORCINE VACCINES
    • 4.1.2. POULTRY VACCINES
    • 4.1.3. LIVESTOCK VACCINES
    • 4.1.4. AQUACULTURE VACCINES
    • 4.1.5. COMPANION ANIMAL VACCINES
    • 4.1.6. OTHER ANIMAL VACCINES
  • 4.2. GLOBAL ANIMAL VACCINE MARKET BY TECHNOLOGY
    • 4.2.1. LIVE WHOLE VIRUS VACCINES
    • 4.2.2. KILLED WHOLE VIRUS VACCINES
    • 4.2.3. SUBUNIT VACCINES
    • 4.2.4. RECOMBINANT VIRUS VACCINES
    • 4.2.5. ANTI-IDIOTYPE ANTIBODIES
    • 4.2.6. DNA VACCINES
    • 4.2.7. GENE DELETED MARKER VACCINES
    • 4.2.8. CHIMERIC VACCINES

5. COMPETITIVE LANDSCAPE

  • 5.1. KEY COMPANY ANALYSIS
  • 5.2. KEY STRATEGY ANALYSIS

6. REGIONAL ANALYSIS

  • 6.1. NORTH AMERICA
    • 6.1.1. UNITED STATES
    • 6.1.2. CANADA
  • 6.2. EUROPE
    • 6.2.1. UNITED KINGDOM
    • 6.2.2. FRANCE
    • 6.2.3. GERMANY
    • 6.2.4. ITALY
    • 6.2.5. SPAIN
    • 6.2.6. REST OF EUROPE
  • 6.3. ASIA PACIFIC
    • 6.3.1. INDIA
    • 6.3.2. CHINA
    • 6.3.3. JAPAN
    • 6.3.4. KOREA
    • 6.3.5. ROAPAC
  • 6.4. REST OF THE WORLD

7. COMPANY PROFILES

  • 7.1. BAYER ANIMAL HEALTH
  • 7.2. BIOGENESIS BAGO A.S
  • 7.3. MERIAL (BOEHRINGER INGELHEIM)
  • 7.4. CEVA ANIMAL HEALTH LLC
  • 7.5. ELANCO (A DIVISION OF ELI-LILLY)
  • 7.6. HESTER BIOSCIENCES LIMITED
  • 7.7. HIPRA
  • 7.8. HYGIEIA BIOLOGICAL LABORATORIES
  • 7.9. INDOVAX PVT. LTD.
  • 7.10. JINYU BIO-TECHNOLOGY CO. LTD.
  • 7.11. MSD ANIMAL HEALTH
  • 7.12. NEOGEN CORPORATION
  • 7.13. NISSEIKEN CO. LTD.
  • 7.14. TEXAS VET LAB, INC.
  • 7.15. UNITED VACCINES, INC.
  • 7.16. VIRBAC S.A
  • 7.17. VENTOQUINOL S.A
  • 7.18. ZOETIS INC.
Back to Top
전화 문의
이용안내
 
BCC Research